| BERGER, Claire |
| Completed | 3 | 51 | Europe, Japan, US | BAX930, rADAMTS13, SHP-655, TAK-755, recombinant ADAMTS13, BAX 930, Standard of care | Baxalta now part of Shire, Takeda Development Center Americas, Inc. | Thrombotic Thrombocytopenic Purpura (TTP) | 12/23 | 05/24 | | |
NCT04683003: A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura |
|
|
| Recruiting | 3 | 77 | Europe, Japan, US, RoW | TAK-755, rADAMTS13; recombinant ADAMTS13; SHP-655; BAX 930 | Takeda, Takeda Development Center Americas, Inc., Shire | Thrombotic Thrombocytopenic Purpura (TTP) | 03/27 | 03/27 | | |
| Recruiting | 3 | 409 | Europe | Everolimus, VOTUBIA, AFINITOR, ONC201, Radiotherapy | Gustave Roussy, Cancer Campus, Grand Paris, Chimerix, Innovative Therapies For Children with Cancer Consortium, Ministry of Health, France | Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant | 09/28 | 09/31 | | |
| Active, not recruiting | 2 | 217 | Europe, Japan, US, RoW | tucatinib, TUKYSA, ARRY-380, ONT-380, trastuzumab, Herceptin, fulvestrant, Faslodex | Seagen Inc., Seagen, Inc. | Uterine Neoplasms, Uterine Cervical Neoplasms, Biliary Tract Neoplasms, Urologic Neoplasms, Carcinoma, Non-Small-Cell Lung, HER2 Mutations Breast Neoplasms | 11/23 | 05/25 | | |
| Active, not recruiting | 2 | 70 | US | tucatinib, TUKYSA, ARRY-380, ONT-380, trastuzumab deruxtecan, T-DXd, Enhertu, DS-8201 | Seagen Inc. | HER2 Positive Breast Cancer | 07/24 | 10/25 | | |
REGOMAIN, NCT04698785: Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas Patients |
|
|
| Recruiting | 2 | 36 | Europe | Treatment by regorafenib and best supportive care, Experimental arm | Centre Leon Berard | Bone Sarcoma, Osteosarcoma | 07/26 | 07/26 | | |
| Not yet recruiting | N/A | 532 | Europe | MOOC, No intervention | Centre Hospitalier Universitaire de Saint Etienne | Long-Term Survivors | 11/25 | 11/25 | | |
MICCHADO, NCT03496402: Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults |
|
|
| Active, not recruiting | N/A | 600 | Europe | Sampling on blood, bone marrow and cerebrospinal fluid | Institut Curie | Neuroblastoma, Rhabdomyosarcoma, Ewing Sarcoma Family of Tumors, Osteosarcoma, Leukemia, Central Nervous System Tumor | 04/27 | 08/27 | | |
| Recruiting | N/A | 168 | Europe | Treatment by Regorafenib, Stivarga, Treatment by Placebo, Standard of care | Centre Leon Berard | Bone Sarcoma, Osteosarcoma, Ewing Sarcoma, Chondrosarcoma, Undifferentiated Pleomorphic Sarcoma, Leiomyosarcoma, Angiosarcoma | 10/26 | 10/26 | | |
Protect-NOW, NCT03695978: Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia a Patients |
|
|
| Recruiting | N/A | 200 | Europe, Canada, US, RoW | | Octapharma | Haemophilia a | 06/30 | 06/30 | | |
BIOPORTAL, NCT05192980: SIOPEN , An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours |
|
|
| Recruiting | N/A | 600 | Europe | No Intervention NA, Bio-sampling | Institut Curie | Neuroblastoma, Ganglioneuroblastoma, Ganglioneuroma | 11/38 | 11/38 | | |
| MASSOUBRE, CATHERINE C |
| Terminated | N/A | 34 | Europe | Mindfulness | Centre Hospitalier Universitaire de Saint Etienne, Fondation de l'Avenir | Schizophrenia | 05/21 | 07/21 | | |
| Terminated | N/A | 17 | Europe | transcranial Direct Current Stimulation (tDCS) | Centre Hospitalier Universitaire de Saint Etienne | Anorexia Nervosa | 05/22 | 07/22 | | |
EfAPA, NCT05477537: Adapted Physical Activity in the Treatment of Anorexia: a Randomised Control Trial |
|
|
| Not yet recruiting | N/A | 220 | Europe | Adapted physical activity program, APA, Treatment as usual group | Fondation Santé des Étudiants de France | Anorexia Nervosa | 01/24 | 08/24 | | |
SPETCA, NCT04864626: Study of the Impact on the Evolution of the Disease in the Medium Term of the Implementation of a System of Extended Follow-up by Telephone Interview of Patients With an Eating Disorder Organized by the Nurses of the Eating Disorder Referral Center |
|
|
| Active, not recruiting | N/A | 250 | Europe | semi-standardized interview, care experience questionary | Centre Hospitalier Universitaire de Saint Etienne | Eating Disorders, Recurrence, Relapse | 09/24 | 06/27 | | |
| Recruiting | N/A | 75 | Europe | PET imaging using [11C]DASB radioligand., Eye Tracker | Centre Hospitalier Universitaire de Saint Etienne | Anorexia Nervosa | 07/25 | 08/25 | | |
RevBED, NCT05385653: Pre-therapeutic Validation of the Virtual Reality-based Exposure Scenario for CBT "ReVBED" for the Induction of Food Craving in Patients With Bulimia and Binge Eating Disorder (BED) |
|
|
| Completed | N/A | 60 | Europe | experimentation of the virtual reality "RevBED", the use of the scenario in VR | Centre Hospitalier Universitaire de Saint Etienne | Bulimia Nervosa, Binge-Eating Disorder | 05/24 | 05/24 | | |
